Alumis Stock (NASDAQ: ALMS) stock price, news, charts, stock research, profile.
You can purchase shares of Alumis (NASDAQ:ALMS) through any online brokerage.
Other companies in Alumis’s space includes: Atea Pharmaceuticals (NASDAQ:AVIR), Third Harmonic Bio (NASDAQ:THRD), Zevra Therapeutics (NASDAQ:ZVRA), Theravance Biopharma (NASDAQ:TBPH) and GH Research (NASDAQ:GHRS).
Alumis has a consensus price target of $30.40.
The stock price for Alumis (NASDAQ: ALMS) is $11.35 last updated November 12, 2024 at 4:00 PM EST.
There are no upcoming dividends for Alumis.
Alumis’s Q3 earnings are confirmed for Tuesday, November 26, 2024.
There is no upcoming split for Alumis.
Alumis is in the Health Care sector and Pharmaceuticals industry. They are listed on the NASDAQ.